DHAKSHINA MOORTHY GANESHAN to Antibodies, Monoclonal, Humanized
This is a "connection" page, showing publications DHAKSHINA MOORTHY GANESHAN has written about Antibodies, Monoclonal, Humanized.
Connection Strength
0.113
-
Randomized phase 2 trial of tremelimumab and durvalumab in combination versus sequentially in recurrent platinum-resistant ovarian cancer. Cancer. 2024 04 01; 130(7):1061-1071.
Score: 0.102
-
Imaging of complications of oncological therapy in the gastrointestinal system. Cancer Imaging. 2012 May 07; 12:163-72.
Score: 0.011